Cancer Journal Citation Rate 2026
0008-543X
eISSN 1045-7410
Wiley
US
Q1 Quartile Established Impact Verified Publisher
About Cancer
Cancer (C) is a peer-reviewed academic journal, published by Wiley in US, catalogued under ISSN 0008-543X (e-ISSN 1045-7410). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 3.74 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.
Cancer Citation Rate 2026 — In Context
Cancer has a 2025 2-Year Citation Rate (OpenAlex) of 3.74, placing it in the Q1 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Cancer operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Cancer should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Cancer against similar journals in the field, use our journal comparison tool.
| ISSN (Print) | 0008-543X |
|---|---|
| ISSN (Online) | 1045-7410 |
| Publisher | Wiley |
| Country | United States |
| APC / Cost | Inquire with Publisher |
In-depth profile & metrics
Cancer is published by Wiley and based in United States.
Its most recent citation rate stands at 3.741.
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Cancer
Live Indexing Status
Updated July 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 3.741 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Research Highlights
Recently published high-impact papers in this journal:
-
Positive rates of endometrial and cervical cytology in ovarian cancer patients with BRCA1/2 germline pathogenic variants
Eitaro Funada, Hidetaka Nomura, Tsubasa Kon • 2026
-
Significance of nodal yield after rectal resection in the TNT era: does count matter?
L. V. O’Connell, N. Murnaghan, A. O’Brien • 2026
-
Azvudine for the treatment of cancer patients with COVID-19: a multicenter, real-world, retrospective, cohort study
Lei Li, Wenjie Liu, Ling WANG • 2026
-
Impact of bladder volume precision control on setup errors and dosimetry in intensity-modulated radiation therapy for cervical cancer
Zijian Lu, Yajun Li, Dehong Luo • 2026
-
Nonadherence to changing guidelines in early breast cancer over two decades
Annikki Aromaa‐Häyhä, Päivi Auvinen, Nea Malila • 2026
Explore More Journals
Metadata
Last updated: Jul 12, 2026
Updated by: system
Get weekly updates
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.